Bayer CropScience Ltd

Bayer Crop Sci. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Bayer CropScience Ltd

₹ 4,826 1.61%
21 Feb - close price
bayer.in BSE: 506285 NSE: BAYERCROP
About

Bayer CropScience is engaged in Agri Care business which primarily includes manufacture, sale and distribution of insecticides, fungicides, herbicide and various other agrochemical products and corn seeds.[1]

Key Points

Business Areas

Website BSE NSE
  • Market Cap ₹ 21,687 Cr.
  • Current Price ₹ 4,826
  • High / Low ₹ 7,197 / 4,217
  • Stock P/E 441
  • Book Value ₹ 84.5
  • Dividend Yield 2.90 %
  • ROCE 20.1 %
  • ROE 15.8 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Stock is trading at 57.1 times its book value
  • Company might be capitalizing the interest cost
  • Earnings include an other income of Rs.83.7 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Multinational

Part of BSE 250 LargeMidCap Index Nifty LargeMidcap 250 BSE 400 MidSmallCap Index Nifty 500 Multicap 50:25:25 Nifty Total Market

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2005 Dec 2006
223 242
194 225
Operating Profit 29 18
OPM % 13% 7%
7 18
Interest 2 3
Depreciation 6 6
Profit before tax 27 27
Tax % 71% 36%
8 17
EPS in Rs 1.97 4.37
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Dec 2005 Dec 2006
667 727
610 692
Operating Profit 57 35
OPM % 9% 5%
50 84
Interest 8 9
Depreciation 23 23
Profit before tax 77 87
Tax % 50% 36%
38 55
EPS in Rs 9.71 14.03
Dividend Payout % 23% 17%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 9%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 15%
Stock Price CAGR
10 Years: 4%
5 Years: 1%
3 Years: 4%
1 Year: -19%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 16%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Dec 2005 Dec 2006
Equity Capital 40 40
Reserves 250 294
120 112
436 468
Total Liabilities 846 914
161 153
CWIP 8 4
Investments 4 4
674 754
Total Assets 846 914

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Dec 2005 Dec 2006
-12 38
-34 -16
25 -26
Net Cash Flow -21 -4

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Dec 2005 Dec 2006
Debtor Days 94 108
Inventory Days 186 163
Days Payable 170 139
Cash Conversion Cycle 111 133
Working Capital Days 112 128
ROCE % 20%

Shareholding Pattern

Numbers in percentages

Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
71.43% 71.43% 71.44% 71.44% 71.44% 71.44% 71.44% 71.44% 71.44% 71.44% 71.44% 71.44%
2.90% 2.95% 3.10% 3.19% 3.18% 3.18% 3.30% 3.53% 3.62% 3.63% 3.30% 3.42%
12.90% 13.10% 12.76% 12.78% 12.74% 13.06% 13.23% 12.70% 12.80% 12.47% 12.08% 11.69%
12.77% 12.51% 12.71% 12.59% 12.64% 12.32% 12.05% 12.33% 12.15% 12.47% 13.18% 13.45%
No. of Shareholders 60,23057,76057,89657,04857,25348,40445,32946,90745,85246,20151,28954,289

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls